May 15, 2021
Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, and both doses are associated with a very low rate of bleeding, according to findings from the open-label, pragmatic ADAPTABLE trial.
The results, presented as a late-breaking clinical trial during the American College of Cardiology 2021 Scientific Session and published simultaneously in the
New England Journal of Medicine, suggest equivalence between the two doses and should help inform clinical practice in the United States, where there is some uncertainty about the right aspirin dose for secondary prevention, say investigators.
ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
For NHRA’s Shawn Langdon, zMAX Dragway Is Site of Some Life-Changing History
Kalitta Motorsports racer returns to site of first Funny Car victory.
By Susan Wade Icon SportswireGetty Images
Kalitta Motorsports racer Shawn Langdon earned his first NHRA pro trophy, in the Top Fuel class, at zMAX Dragway in Charlotte, N.C., in the fall of 2012, The Funny Car breakthrough came just two weeks after Langdon promised a Wally trophy to his father, Chad Langdon, who was overcoming cancer and recuperating from a liver transplant.
Langdon and Del Worsham are the only drivers to win in both NHRA Top Fuel and Funny Car at zMAX Dragway.
Dr. Michael Bilof and Dr. Basil Yurcisin of Garden State Bariatrics & Wellness Center Named NJ Top Docs
Share Article
NJ Top Docs is proud to present Dr. Michael Bilof and Dr. Basil Yurcisin of Garden State Bariatrics & Wellness Center for 2021.
Garden State Bariatrics SCOTCH PLAINS, N.J. (PRWEB) May 12, 2021 Dr. Michael Bilof and Dr. Basil Yurcisin of Garden State Bariatrics & Wellness Center have been re-reviewed and approved by NJ Top Docs for the tenth consecutive year. Both doctors are highly educated, have years of experience and are recognized as two of the top bariatric surgeons in New Jersey.
Dr. Bilof and Dr. Yurcisin understand that their patients have chosen a complete lifestyle change which requires expertise, passion and the utmost compassion. They are both Fellows of the American College of Surgeons and the American Society of Metabolic & Bariatric Surgery.
email article
Black men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (Zytiga) plus prednisone had similar survival outcomes but more toxicity compared with white men, a multicenter prospective study showed.
Median radiographic progression-free survival (PFS), the study s primary outcome, was similar between the two groups, at 16.6 and 16.8 months for the Black and white patients, respectively, reported Daniel George, MD, of Duke University Medical Center in Durham, North Carolina, and colleagues.
And median overall survival was nearly identical (35.9 vs 35.7 months, respectively). In addition, Black men had a median time to prostate-specific antigen (PSA) progression (TTP) of 16.6 months compared with 11.5 months for white men, as shown in the team s study in